Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

HIV vaccine development: strategies for preclinical and clinical investigation.

Shapiro SZ.

AIDS Res Hum Retroviruses. 2013 Nov;29(11):1401-6. doi: 10.1089/AID.2012.0337. Epub 2013 Mar 8. Review.

2.

Clinical development of candidate HIV vaccines: different problems for different vaccines.

Shapiro SZ.

AIDS Res Hum Retroviruses. 2014 Apr;30(4):325-9. doi: 10.1089/AID.2013.0114. Epub 2013 Nov 22. Review.

3.

New directions for HIV vaccine development from animal models.

McChesney MB, Miller CJ.

Curr Opin HIV AIDS. 2013 Sep;8(5):376-81. doi: 10.1097/COH.0b013e328363d3a2. Review.

4.

Challenges in mucosal HIV vaccine development: lessons from non-human primate models.

Tuero I, Robert-Guroff M.

Viruses. 2014 Aug 15;6(8):3129-58. doi: 10.3390/v6083129. Review.

5.

Commentary on Shapiro: clinical development of candidate HIV vaccines: different problems for different vaccines.

Hope TJ, Betts MR.

AIDS Res Hum Retroviruses. 2014 Apr;30(4):330. doi: 10.1089/AID.2014.0047. No abstract available.

6.

Comment on clinical development of candidate HIV vaccines: different problems for different vaccines.

McMichael A, Dorrell L.

AIDS Res Hum Retroviruses. 2014 Apr;30(4):331-2. doi: 10.1089/AID.2014.0041. No abstract available.

7.

Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspective.

Staprans SI, Feinberg MB, Shiver JW, Casimiro DR.

Curr Opin HIV AIDS. 2010 Sep;5(5):377-85. doi: 10.1097/COH.0b013e32833d2e19. Review.

PMID:
20978377
8.

A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds.

Hope TJ, Marrazzo JM.

AIDS Res Hum Retroviruses. 2015 Nov;31(11):1055-9. doi: 10.1089/AID.2015.0310. Review.

9.

The future of HIV vaccine research and the role of the Global HIV Vaccine Enterprise.

Voronin Y, Manrique A, Bernstein A.

Curr Opin HIV AIDS. 2010 Sep;5(5):414-20. doi: 10.1097/COH.0b013e32833cfe32. Review.

10.

HIV-Host Interactions: Implications for Vaccine Design.

Haynes BF, Shaw GM, Korber B, Kelsoe G, Sodroski J, Hahn BH, Borrow P, McMichael AJ.

Cell Host Microbe. 2016 Mar 9;19(3):292-303. doi: 10.1016/j.chom.2016.02.002. Epub 2016 Feb 25. Review.

11.

HIV vaccine development: Lessons from the past, informing the future.

Bradac J, Dieffenbach CW.

IDrugs. 2009 Jul;12(7):435-9. Review.

PMID:
19579164
12.

Recent progress in HIV vaccines inducing mucosal immune responses.

Pavot V, Rochereau N, Lawrence P, Girard MP, Genin C, Verrier B, Paul S.

AIDS. 2014 Jul 31;28(12):1701-18. doi: 10.1097/QAD.0000000000000308. Review.

PMID:
25009956
13.

HIV vaccine: Can it be developed in the 21st century?

Verma R, Khanna P, Chawla S, Dhankar M.

Hum Vaccin Immunother. 2016;12(1):222-4. doi: 10.1080/21645515.2015.1064571.

14.

A review of vaccine research and development: the human immunodeficiency virus (HIV).

Girard MP, Osmanov SK, Kieny MP.

Vaccine. 2006 May 8;24(19):4062-81. Epub 2006 Feb 28. Review.

PMID:
16530298
15.

Vaccine development against HIV-1: current perspectives and future directions.

Edgeworth RL, San JH, Rosenzweig JA, Nguyen NL, Boyer JD, Ugen KE.

Immunol Res. 2002;25(1):53-74. Review.

PMID:
11868934
16.

Clinical trials of HIV vaccines.

Graham BS.

Annu Rev Med. 2002;53:207-21. Review.

PMID:
11818471
17.

Recent advances in humanized mice: accelerating the development of an HIV vaccine.

Tager AM, Pensiero M, Allen TM.

J Infect Dis. 2013 Nov;208 Suppl 2:S121-4. doi: 10.1093/infdis/jit451.

18.

HIV vaccines in infants and children.

Lambert JS.

Paediatr Drugs. 2005;7(5):267-76. Review.

PMID:
16220994
19.

Prospects for a globally effective HIV-1 vaccine.

Excler JL, Robb ML, Kim JH.

Vaccine. 2015 Nov 27;33 Suppl 4:D4-12. doi: 10.1016/j.vaccine.2015.03.059. Epub 2015 Jun 20. Review.

PMID:
26100921
20.

State of the science. HIV vaccine development.

Grady C, Kelly G.

Nurs Clin North Am. 1996 Mar;31(1):25-39. Review.

PMID:
8604385

Supplemental Content

Support Center